Income Statement
CBDMD, INC.
YCBD
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Sep 30, 2025 2025 FY | Sep 30, 2024 2024 FY | Sep 30, 2023 2023 FY | Sep 30, 2022 2022 FY | Sep 30, 2021 2021 FY | Sep 30, 2020 2020 FY | Sep 30, 2019 2019 FY | Sep 30, 2018 2018 FY | Sep 30, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
19.19 | 19.48 | 24.16 | 35.40 | 44.48 | 41.88 | 23.65 | 8.42 | 4.47 |
|
Cost of Revenue
|
7.22 | 7.49 | 9.18 | 13.07 | 14.50 | 15.51 | 9.14 | 2.67 | 1.36 |
|
Gross Profit
|
11.97 | 12.00 | 14.98 | 22.34 | 29.99 | 26.37 | 14.51 | 5.75 | 3.12 |
|
Operating Expenses
|
0.00 | 0.00 | 0.00 | 0.00 | 49.60 | 43.95 | 29.31 | 5.63 | 3.36 |
|
Research & Development
|
- | - | - | - | - | - | - | - | - |
|
Selling, General & Administrative
|
- | - | - | - | - | - | - | - | - |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - |
|
Operating Income
|
11.97 | 12.00 | 14.98 | 22.34 | -19.62 | -17.58 | -14.80 | 0.12 | -0.24 |
|
Non-Operating Income
|
14.01 | 15.70 | 37.92 | 92.42 | 4.67 | -28.89 | 32.99 | - | - |
|
Interest Income
|
- | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | 0.00 | 0.50 |
|
Other Non-Op Income / Expense
|
- | - | 0.00 | 0.24 | - | - | - | - | - |
|
Income Before Tax
|
-2.04 | -3.70 | -22.94 | -70.08 | -23.39 | 11.31 | -47.79 | - | - |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | -0.90 | -1.30 | 3.57 | 0.02 | 0.03 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - |
|
Net Income
|
-2.04 | -3.70 | -22.94 | -70.08 | -23.39 | 12.60 | -51.36 | 1.79 | -2.06 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Sep 30, 2025 2025 FY | Sep 30, 2024 2024 FY | Sep 30, 2023 2023 FY | Sep 30, 2022 2022 FY | Sep 30, 2021 2021 FY | Sep 30, 2020 2020 FY | Sep 30, 2019 2019 FY | Sep 30, 2018 2018 FY | Sep 30, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - |
|
EBITDA
|
11.97 | 12.00 | 14.98 | 22.34 | -18.60 | -16.86 | -14.51 | 0.34 | -0.17 |
|
Earnings Per Share (Basic)
|
-1.09 | -1.79 | -13.32 | -1.24 | -0.47 | 0.28 | -2.82 | - | - |
|
Diluted EPS
|
-1.09 | -1.79 | -13.32 | -1.24 | -0.47 | 0.28 | 0.00 | - | - |
|
Weighted Average Shares
|
4.02 | 4.31 | 2.02 | 59.75 | 54.94 | 44.14 | 17.89 | - | - |
|
Diluted Weighted Avg Shares
|
4.02 | 4.31 | 2.02 | 59.75 | 54.94 | 45.17 | 17.89 | - | - |
|
Comprehensive Income
|
-4.37 | -7.70 | -26.94 | -74.09 | -23.39 | 12.60 | -51.36 | -2.45 | - |